OraSure Technologies stock reports USD 30.6 million Q2 revenue

Published on 10/07/2026 at 05:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

OraSure Technologies stock was last at USD 3.77 on October 6, 2026, after an 8.27 percent daily decline. Q3 revenue guidance stands at USD 29.5 million to USD 32.5 million.

OSUR, US68554V1089, Illustration mit AI erstellt.

OraSure Technologies (ISIN US68554V1089) reported USD 30.6 million in second-quarter 2026 revenue and USD 6.8 million in net income. The stock was last at USD 3.77 on Nasdaq on October 6, 2026, down 8.27 percent from the prior close.

Q2 revenue and margin improve

According to OraSure Technologies in its August 5, 2026 release, revenue for the three months ended June 30, 2026 reached USD 30.6 million, while GAAP gross margin was 43.5 percent.

The finance picture improved sequentially: Q1 revenue was USD 27.9 million and Q1 net income was negative USD 23.3 million, compared with USD 6.8 million of net income in Q2. Q2 gross margin also exceeded the 42.3 percent reported for Q1 by 1.2 percentage points.

Diagnostics lead the operating mix

Yahoo Finance reports that diagnostic products generated USD 19.4 million of Q2 revenue and grew 14.7 percent sequentially. Sample Management Solutions contributed USD 9.9 million, up 9 percent from Q1.

Management's Q3 revenue guidance is USD 29.5 million to USD 32.5 million, with gross margin expected to remain similar to Q2, according to the same August 5 earnings call. Operating cash flow was negative USD 9.9 million in Q2, keeping cash conversion central to the next results cycle.

Consensus stays close to market price

ToAlpha lists one analyst at Hold, with a consensus price target of USD 4.00. That target lies 6.1 percent above the USD 3.77 Nasdaq price, while the reported 52-week range runs from USD 2.08 to USD 4.58.

The balance sheet gives the operating outlook some flexibility: OraSure ended Q2 with USD 160.6 million in cash and zero reported debt. The company operates through diagnostic products and sample management solutions, including oral-fluid testing and molecular sample collection.

OraSure Technologies stock last at USD 3.77

OraSure Technologies stock was last at USD 3.77 on Nasdaq on October 6, 2026 at 4:00 p.m. ET, with a market capitalization of USD 259.6 million and volume of 534,020 shares.